AACR logo

More articles from Cancer Biology and Signal Transduction

Identification of the Serine Biosynthesis Pathway as a Critical Component of BRAF Inhibitor Resistance of Melanoma, Pancreatic, and Non–Small Cell Lung Cancer Cells
Kayleigh C. Ross, Andrew J. Andrews, Christopher D. Marion, Timothy J. Yen, Vikram Bhattacharjee

Molecular Cancer Therapeutics Aug 2017, 16 (8) 1596-1609; DOI: 10.1158/1535-7163.MCT-16-0798
Sensitization of EGFR Wild-Type Non–Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib
Judith Raimbourg, Marie-Pierre Joalland, Mathilde Cabart, Ludmilla de Plater, Fanny Bouquet, Ariel Savina, Didier Decaudin, Jaafar Bennouna, François M. Vallette, Lisenn Lalier

Molecular Cancer Therapeutics Aug 2017, 16 (8) 1634-1644; DOI: 10.1158/1535-7163.MCT-17-0075
Reactivation of the p90RSK–CDC25C Pathway Leads to Bypass of the Ganetespib-Induced G₂–M Arrest and Mediates Acquired Resistance to Ganetespib in KRAS-Mutant NSCLC
Suman Chatterjee, Eric H.-B. Huang, Ian Christie, Timothy F. Burns

Molecular Cancer Therapeutics Aug 2017, 16 (8) 1658-1668; DOI: 10.1158/1535-7163.MCT-17-0114
Inhibition of Heparanase in Pediatric Brain Tumor Cells Attenuates their Proliferation, Invasive Capacity, and In Vivo Tumor Growth
Argyris Spyrou, Soumi Kundu, Lulu Haseeb, Di Yu, Tommie Olofsson, Keith Dredge, Edward Hammond, Uri Barash, Israel Vlodavsky, Karin Forsberg-Nilsson

Molecular Cancer Therapeutics Aug 2017, 16 (8) 1705-1716; DOI: 10.1158/1535-7163.MCT-16-0900
Lectin, Galactoside-Binding Soluble 3 Binding Protein Promotes 17-N-Allylamino-17-demethoxygeldanamycin Resistance through PI3K/Akt Pathway in Lung Cancer Cell Line
Jong Kyu Woo, Jeong-Eun Jang, Ju-Hee Kang, Je Kyung Seong, Yeo Sung Yoon, Hyoung-Chin Kim, Sang-Jin Lee, Seung Hyun Oh

Molecular Cancer Therapeutics Jul 2017, 16 (7) 1355-1365; DOI: 10.1158/1535-7163.MCT-16-0574
TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing
Tieju Liu, Huizhi Sun, Dongwang Zhu, Xueyi Dong, Fang Liu, Xiaohui Liang, Chen Chen, Bing Shao, Meili Wang, Yi Wang, Baocun Sun

Molecular Cancer Therapeutics Jul 2017, 16 (7) 1377-1388; DOI: 10.1158/1535-7163.MCT-17-0026
Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer
Michael A. Gordon, Nicholas C. D'Amato, Haihua Gu, Beatrice Babbs, Julia Wulfkuhle, Emanuel F. Petricoin, Isela Gallagher, Ting Dong, Kathleen Torkko, Bolin Liu, Anthony Elias, Jennifer K. Richer

Molecular Cancer Therapeutics Jul 2017, 16 (7) 1389-1400; DOI: 10.1158/1535-7163.MCT-17-0111
Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody–Drug Conjugates
Fu Li, Michelle Ulrich, Mechthild Jonas, Ivan J. Stone, Germein Linares, Xinqun Zhang, Lori Westendorf, Dennis R. Benjamin, Che-Leung Law

Molecular Cancer Therapeutics Jul 2017, 16 (7) 1347-1354; DOI: 10.1158/1535-7163.MCT-17-0019
Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia
Jixin Ding, Melissa L. Fishel, April M. Reed, Erin McAdams, Magdalena B. Czader, Angelo A. Cardoso, Mark R. Kelley

Molecular Cancer Therapeutics Jul 2017, 16 (7) 1401-1411; DOI: 10.1158/1535-7163.MCT-17-0099
Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer Cells
Pol Gimenez-Xavier, Eva Pros, Ester Bonastre, Sebastian Moran, Ana Aza, Osvaldo Graña, Gonzalo Gomez-Lopez, Sophia Derdak, Marc Dabad, Anna Esteve-Codina, Jose R. Hernandez Mora, Diana Salinas-Chaparro, Manel Esteller, David Pisano, Montse Sanchez-Cespedes

Molecular Cancer Therapeutics Jul 2017, 16 (7) 1366-1376; DOI: 10.1158/1535-7163.MCT-17-0104

Main menu

User menu

Search

More articles from Cancer Biology and Signal Transduction

Pages

Articles

Info for

About MCT